Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilocarpine 1.25% Eye Drops for Presbyopia
NCT05564832Phase 1Unknown
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Aug 2022
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of pilocarpine in presbyopia (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Changes of near vision at 1 hour. Status: unknown.
02
Drugs
pilocarpine
03
Conditions
presbyopia
Beyond the preview
Go deeper on NCT05564832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05564832.